Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

GP's hep B blitz in misusers

GPs are too cautious in their use of ß-blockers and ACE inhibitors and need to be updated on the latest evidence on treating heart failure, a new Europe-wide trial concludes.

Only 7-29 per cent of

GPs achieved target doses of ß-blockers and 18-30 per cent hit target doses for ACE inhibitors, according to the study, published in last month's European Journal of Heart Failure.

The SHAPE trial analysed the prescribing of 3,000 GPs from nine European countries, including the UK.

It also found 75 per cent of GPs diagnosed heart failure on the basis of signs and symptoms alone, although 64 per cent believed an echocardiogram was needed for accurate diagnosis.

And there was evidence that GPs treated patients differently according to their age.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say